Description

▪ Introduction
Drosten 200 by Pharma Nevis delivers 200 mg/mL of Drostanolone Enanthate, an injectable anabolic androgenic steroid formulated for clinical use in managing catabolic conditions such as muscle-wasting disorders and hormonal imbalance. With a mild androgenic profile and low estrogenic activity, Drostanolone Enanthate is preferred in medical protocols aiming to preserve lean muscle mass without causing water retention or significant androgenic side effects.

The long-acting enanthate ester provides steady hormone release, suitable for once or twice weekly administration based on clinical needs. Its anabolic properties support muscle maintenance, tissue regeneration, and recovery in patients recovering from chronic illness, surgery, or trauma.

Manufactured under GMP-compliant pharmaceutical conditions, Drosten 200 ensures sterility, purity, and batch consistency for licensed medical professionals requiring effective long-acting anabolic therapy.

▪ Product Details

• Active Ingredient: Drostanolone Enanthate

• Dosage Strength: 200 mg/mL

• Form: Injectable solution (intramuscular)

• Brand: Pharma Nevis

• Package Size: 10 mL multi-dose vial

• Intended Use: Licensed medical use only

▪ Pharmacokinetics
Drostanolone Enanthate features an approximate half-life of 7–10 days, allowing for dosing intervals of once or twice weekly under medical supervision.

▪ Usage Recommendations
Typical Dosage: As prescribed by a qualified healthcare provider
Route: Intramuscular injection
Frequency: Weekly or biweekly depending on clinical protocol

▪ Disclaimer
For licensed medical use only. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with contraindicated medical conditions. Not intended for performance enhancement or recreational use. All use must comply with applicable medical regulations and be administered by healthcare professionals.